----
Current ValuationThe current P/E ratio is 13.59, below the reasonable range, cheaper than 87.26% of the time in the past 5 years, and the industry ranks 7/54, the industry Median -0.19.
13.59xP/E
$67.00Stock price
$4.93Earnings per share
13.59xP/E
Stock price$67.00Earnings per share$4.93
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 17.79x
- Typical range
- 15.09x–22.66x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
054108162216
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
ULUSUnilever | 13.59x | 17.84% | $146.11B |
BDRFYUSBeiersdorf | 18.62x | -- | $20.25B |
NATRUSNatures Sunshine | 12.07x | 0.47% | $218.36M |
NAGEUSNiagen Bioscience | 12.47x | 42.00% | $199.40M |
FTLFUSFitLife Brands | 12.40x | 37.30% | $77.24M |
LFVNUSLifevantage | 14.77x | 51.25% | $74.91M |
AXILUSAXIL Brands | 14.13x | 112.12% | $39.37M |
UGUSUnited-Guardian | 12.67x | -- | $31.24M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
